Patents by Inventor Jens Damsgaard Mikkelsen

Jens Damsgaard Mikkelsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel peptide agonists of GLP-1 activity
    Publication number: 20040106547
    Abstract: Novel peptide agonists of GLP-1 activity useful for lowering blood glucose levels. The novel peptides comprise variants of the GLP-1 or the exendin-4 polypeptide sequence and are pharmacologically active and stable. These peptides are useful in the treatment of diseases that benefit from regulation of excess levels of blood glucose and/or regulation of gastric emptying, such as diabetes and eating disorders.
    Type: Application
    Filed: November 8, 2002
    Publication date: June 3, 2004
    Applicant: Zealand Pharma A/S
    Inventors: Bjarne Due Larsen, Jens Damsgaard Mikkelsen, Soren Neve
  • Peptide agonists of GLP-1 activity
    Patent number: 6528486
    Abstract: The present invention relates to novel peptide conjugates which have increased stability and are useful in the treatment of excess levels of blood glucose.
    Type: Grant
    Filed: July 12, 2000
    Date of Patent: March 4, 2003
    Assignee: Zealand Pharma A/S
    Inventors: Bjarne Due Larsen, Jens Damsgaard Mikkelsen, Søren Neve